Clinical Trial Update: Sprix for Postoperative Pain Control Following Gynecologic Surgery [Phase 4]

View source ↗

Summary

Phase 4 trial of Sprix for postoperative pain control after gynecologic surgery has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain Management After Gynecologic Surgery

Drugs mentioned

• SPRIX (ketorolac tromethamine)

Snippet

Sponsor: University of Louisville | Conditions: Post Operative Pain Control, Narcotic Use | Phase 4 | Status: WITHDRAWN